1549 related articles for article (PubMed ID: 12768297)
1. The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy.
Smrcek JM; Gembruch U; Krokowski M; Berg C; Krapp M; Geipel A; Germer U
Arch Gynecol Obstet; 2003 Jun; 268(2):94-101. PubMed ID: 12768297
[TBL] [Abstract][Full Text] [Related]
2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
[TBL] [Abstract][Full Text] [Related]
4. Biometry of the fetal heart between 10 and 17 weeks of gestation.
Gembruch U; Shi C; Smrcek JM
Fetal Diagn Ther; 2000; 15(1):20-31. PubMed ID: 10705210
[TBL] [Abstract][Full Text] [Related]
5. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency.
Lopes LM; Brizot ML; Lopes MA; Ayello VD; Schultz R; Zugaib M
Ultrasound Obstet Gynecol; 2003 Nov; 22(5):470-8. PubMed ID: 14618659
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis and outcome for fetuses with congenital absence of the pulmonary valve.
Galindo A; Gutiérrez-Larraya F; Martínez JM; Del Rio M; Grañeras A; Velasco JM; Puerto B; Gratacos E
Ultrasound Obstet Gynecol; 2006 Jul; 28(1):32-9. PubMed ID: 16795129
[TBL] [Abstract][Full Text] [Related]
8. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
9. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
10. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
11. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
[TBL] [Abstract][Full Text] [Related]
12. First-trimester fetal cardiac examination using spatiotemporal image correlation, tomographic ultrasound and color Doppler imaging for the diagnosis of complex congenital heart disease in high-risk patients.
Turan S; Turan OM; Desai A; Harman CR; Baschat AA
Ultrasound Obstet Gynecol; 2014 Nov; 44(5):562-7. PubMed ID: 24585667
[TBL] [Abstract][Full Text] [Related]
13. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in fetal biometry and cerebroplacental hemodynamics in fetuses with congenital heart disease.
Ruiz A; Cruz-Lemini M; Masoller N; Sanz-Cortés M; Ferrer Q; Ribera I; Martínez JM; Crispi F; Arévalo S; Gómez O; Pérez-Hoyos S; Carreras E; Gratacós E; Llurba E
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):379-386. PubMed ID: 27214694
[TBL] [Abstract][Full Text] [Related]
15. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
Becker R; Wegner RD
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
[TBL] [Abstract][Full Text] [Related]
16. First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography.
Achiron R; Rotstein Z; Lipitz S; Mashiach S; Hegesh J
Obstet Gynecol; 1994 Jul; 84(1):69-72. PubMed ID: 8008327
[TBL] [Abstract][Full Text] [Related]
17. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A; Huggon I; Areias JC; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Nov; 14(5):307-10. PubMed ID: 10623988
[TBL] [Abstract][Full Text] [Related]
18. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects.
Chelemen T; Syngelaki A; Maiz N; Allan L; Nicolaides KH
Fetal Diagn Ther; 2011; 29(2):127-34. PubMed ID: 21160164
[TBL] [Abstract][Full Text] [Related]
19. First-Trimester Echocardiographic Features and Perinatal Outcomes in Fetuses With Congenital Absence of the Aortic Valve.
Yu R; Li SL; Luo GY; Wen HX; Ouyang SY; Chen CY; Yuan Y
J Ultrasound Med; 2016 Apr; 35(4):739-45. PubMed ID: 26939599
[TBL] [Abstract][Full Text] [Related]
20. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
